image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates. 

CXCR2

Family: Chemokine receptors

This receptor has a proposed ligand; see the Latest Pairings page for more information.

Contents:
Gene and Protein Information
Previous and Unofficial Names
Database Links
Agonists
Antagonists
Transduction Mechanisms
Tissue Distribution
Expression Datasets
Functional Assays
Physiological Functions
Physiological Consequences of Altering Gene Expression
Phenotypes, Alleles and Disease Models
Biologically Significant Variants
References
Gene and Protein Information
class A G protein-coupled receptor
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human 7 360 2q35 CXCR2 chemokine (C-X-C motif) receptor 2 25,34
Mouse 7 359 1 C3 Cxcr2 chemokine (C-X-C motif) receptor 2 6
Rat 7 359 9q33 Cxcr2 chemokine (C-X-C motif) receptor 2 11
Previous and Unofficial Names
Names References
IL-8R2
IL8Rβ
IL8RB 25
KC receptor 6
IL8RB
IL-8 receptor type II
IL-8 receptor β
CMKAR2
CD182
interleukin 8 receptor, beta
C-X-C chemokine receptor type 2
CXC-R2
CXCR-2
GRO/MGSA receptor
IL-8R B
Interleukin 8 receptor beta
chemokine (C-X-C) receptor 2
high affinity interleukin-8 receptor B
CD128
IL-8Rh
IL-8rb
Gpcr16
IL8RA
Database Links
ChEMBL Target 10773 (Hs)
Ensembl ENSG00000180871 (Hs), ENSMUSG00000026180 (Mm), ENSRNOG00000014269 (Rn)
Entrez Gene 3579 (Hs), 12765 (Mm), 29385 (Rn)
GeneCards CXCR2 (Hs)
GenitoUrinary Development Molecular Anatomy Project Cxcr2 (Mm)
HomoloGene 10439 (Hs)
Human Protein Reference Database 00907 (Hs)
InterPro P25025 (Hs), P35343 (Mm), P35407 (Rn)
KEGG Gene hsa:3579 (Hs), mmu:12765 (Mm), rno:29385 (Rn)
OMIM 146928 (Hs)
PharmGKB Gene PA29843 (Hs)
PhosphoSitePlus P25025 (Hs), P35343 (Mm), P35407 (Rn)
Protein Ontology (PRO) PRO:000001257 (Hs)
RefSeq Nucleotide NM_001557 (Hs), NM_009909 (Mm), NM_017183 (Rn)
RefSeq Protein NP_001548 (Hs), NP_034039 (Mm), NP_058879 (Rn)
TreeFam ENSG00000180871 (Hs), ENSMUSG00000026180 (Mm), ENSRNOG00000014269 (Rn)
UniGene Hs. 846 (Hs)
UniProt P25025 (Hs), P35343 (Mm), P35407 (Rn)
Wikipedia CXCR2
Chemokine receptors
Search for 3D structures on the PDB
Search by keyword: Chemokine receptors CXCR2 Search by accession number: P35407, P25025, P35343
Natural/Endogenous Ligand(s)
CXCL1 {Sp: Human} , CXCL1 {Sp: Mouse} , CXCL1 {Sp: Rat}
CXCL2 {Sp: Human} , CXCL2 {Sp: Mouse} , CXCL2 {Sp: Rat}
CXCL3 {Sp: Rat} , CXCL3 {Sp: Human} , CXCL3 {Sp: Mouse}
CXCL5 {Sp: Mouse} , CXCL5 {Sp: Rat} , CXCL5 {Sp: Human}
CXCL6 {Sp: Human}
CXCL7 {Sp: Human}
CXCL8 {Sp: Human}
Comments: macrophage derived lectin is a proposed ligand, single publication
Agonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
[125I]CXCL8 (human) Hs Full agonist 9.0 – 9.4 pKd 16,38
[125I]KC-Tyr Mm Full agonist 8.4 pKd 6
CXCL6 {Sp: Human} Hs Full agonist 7.0 pKd 44
CXCL8 {Sp: Human} Hs Full agonist 8.8 – 9.5 pKi 4,16,25,41,43
CXCL1 {Sp: Human} Hs Full agonist 8.4 – 9.7 pKi 16,25,43
CXCL1 {Sp: Rat} Mm Full agonist 8.8 pKi 6
CXCL1 {Sp: Human} Mm Full agonist 8.1 pKi 6
CXCL1 {Sp: Rat} Mm Full agonist 7.2 pKi 6
CXCL8 {Sp: Human} Mm Full agonist 6.4 pKi 6
CXCL3 {Sp: Human} Hs Full agonist 7.8 – 9.2 pIC50 3
CXCL2 {Sp: Human} Hs Full agonist 7.0 – 9.1 pIC50 3
CXCL5 {Sp: Human} Hs Full agonist 6.9 – 9.0 pIC50 3
CXCL7 {Sp: Human} Hs Full agonist 6.3 – 9.3 pIC50 3
View species-specific agonist tables
Antagonists
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Affinity Units Reference
SB 225002 Hs Antagonist 7.7 pIC50 40
SK&F 83589 Hs Antagonist 6.3 pIC50 40

Explore drug-target interactions for this set of compounds using iPHACE

Primary Transduction Mechanisms
Transducer Effector/Response
Gi/Go family Adenylate cyclase inhibition
Calcium channel
Comments:  The βγ subunit of the Gi G protein is necessary for chemotaxis [35] and calcium mobilisation [16].
References:  13,16,35
Tissue Distribution
Neutrophils.
Species:  Human
Technique:  Western blotting.
References:  27
Mast cells.
Species:  Human
Technique:  RNAse protection assay and flow cytometry.
References:  36
CNS: hippocampus, dentate nucleus, pontine nuclei, locus coeruleus, paraventricular nucleus, and in the anterior horn, interomediolateral cell column, and Clarke's column of the spinal cord.
Species:  Human
Technique:  Immunohistochemistry.
References:  19
Polymorphonuclear neutrophils.
Species:  Human
Technique:  Flow cytometry.
References:  10
Bronchial epithelial cells.
Species:  Human
Technique:  RT-PCR and flow cytometry.
References:  12
Urinary tract epithelial cells.
Species:  Human
Technique:  Immunohistochemistry.
References:  14
Chondrocytes.
Species:  Human
Technique:  Flow cytometry.
References:  29
Umbilical vein endothelial cells (HUVECs).
Species:  Human
Technique:  immunocytochemistry.
References:  26
Basophils.
Species:  Human
Technique:  Flow cytometry.
References:  20,37
Basophils.
Species:  Human
Technique:  RT-PCR.
References:  20
Peritoneal exudate cells.
Species:  Mouse
Technique:  Northern blotting.
References:  6
Alveolar macrophages.
Species:  Mouse
Technique:  Immunohistochemistry.
References:  33
Hippocampal neurons.
Species:  Rat
Technique:  RT-PCR.
References:  30
Lung, speen, neutrophil.
Species:  Rat
Technique:  RNase protection assay and Northern blotting.
References:  11
Expression Datasets

Click here to show/hide data

Log average relative transcript abundance in mouse tissues measured by qPCR from Regard, J.B., Sato, I.T., and Coughlin, S.R. (2008). Anatomical profiling of G protein-coupled receptor expression. Cell, 135(3): 561-71. [PMID:18984166] [Raw data: website]

There should be a chart of expression data here, you may need to enable JavaScript!
Functional Assays
Measurement of intracellular Ca2+ levels in HEK 293 cells transfected with the human CXCR2 receptor.
Species:  Human
Tissue:  HEK 293 cells.
Response measured:  Increase in intracellular Ca2+.
References:  25,44-45
Measurement of intracellular Ca2+ levels in HEK 293 cells transfected with the rat CXCR2 receptor.
Species:  Rat
Tissue:  HEK 293 cells.
Response measured:  Increase in intracellular Ca2+.
References:  11
Measurement of chemotaxis of mouse peripheral blood leukocytes endogenously expressing the CXCR2 receptor.
Species:  Mouse
Tissue:  Peripheral blood leukocytes.
Response measured:  Chemotaxis.
References:  6
Measurement of Ca2+ levels in Jurkat cells transfected with the human CXCR2 receptor.
Species:  Human
Tissue:  Jurkat cells.
Response measured:  Ca2+ mobilisation.
References:  22-23,42
Measurement of elastase released by human neutrophils endogenously expressing the CXCR2 receptor.
Species:  Human
Tissue:  Neutrophils.
Response measured:  Release of elastase.
References:  22-23,42
Measurement of chemotaxis of human mast cells, HMC-1, endogenously expressing the CXCR2 receptor.
Species:  Human
Tissue:  HMC-1 cells.
Response measured:  Chemotaxis.
References:  36
Measurement of focal adhesion kinase (FAK) activity and chemotaxis of HEK 293 and RBL cells transfected with the CXCR2 receptor.
Species:  Human
Tissue:  HEK 293 and RBL cells.
Response measured:  FAK phosphorylation and chemotaxis.
References:  13
Measurement of chemotaxis of HEK 293 cells transfected with the human CXCR2 receptor.
Species:  Human
Tissue:  HEK 293 cells.
Response measured:  Chemotaxis.
References:  13,44
Measurement of cAMP levels in CHO cells transfected with the human CXCR2 receptor.
Species:  Human
Tissue:  CHO cells.
Response measured:  Inhibition of cAMP accumulation.
References:  16
Physiological Functions
Chemotaxis.
Species:  Human
Tissue:  Mast cells.
References:  36
Chemotaxis.
Species:  Human
Tissue:  Neutrophils.
References:  40
Hypertrophic differentiation.
Species:  Human
Tissue:  Chondrocytes.
References:  29
Cell proliferation and inhibition of apoptosis.
Species:  Human
Tissue:  Umbilical vein endothelial cells.
References:  26
Cutaneous wound repair.
Species:  Mouse
Tissue:  In vivo.
References:  9,32
Chemotaxis.
Species:  Human
Tissue:  Microvascular endothelial cells (HMVECs).
References:  2
Neovascularisation (angiogenesis).
Species:  Rat
Tissue:  Cornea.
References:  2
Neutrophil recruitment.
Species:  Mouse
Tissue:  In vivo.
References:  8,15,17,24,32
Transendothelial movement of mast cell progenitors into intestinal tissue.
Species:  Mouse
Tissue:  In vivo (small intestine).
References:  1
Macrophage recruitment.
Species:  Rat
Tissue:  In vivo (kidney).
References:  46
Macrophage recruitment.
Species:  Mouse
Tissue:  In vivo.
References:  5
Physiological Consequences of Altering Gene Expression
CXCR2 knockout mice exhibit enhanced numbers of myeloid progenitor cells in the femur, spleen and blood.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  7
CXCR2 receptor knockout mice exhibit delayed cutaneous wound healing (delayed epithelialisation and decreased neovascularisation). They have defective neutrophil recruitment as well as altered monocyte recruitment and Il-1β secretion.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  9
CXCR2 knockout mice exhibit impaired corneal neovascular (angiogenic) response.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  2
CXCR2 knockout mice exhibit impaired neutrophil recruitment during inflammatory responses.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  8,15,17,21,24,32
CXCR2 receptor knockout mice exhibit decreased airway hyperreactivity in response to respiratory syncytial virus (RSV) infection compared to wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  33
CXCR2 knockout mice subjected to ischaemia-reperfusion exhibit reduced myocardial infarct size and reduced inflammatory cell recruitment compared to wild-type mice.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  39
CXCR2 receptor knockout mice exhibit a decreased number of mast cell progenitors found in the small intestine.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  1
CXCR2 knockin mice have been developed, where the mouse CXCR2 receptor is replaced by human CXCR2. This mouse model demonstrates that both the mouse and human forms of the receptor are functionally equivalent. This model allows us to test the role of the human receptor using animal studies.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  31
CXCR2 receptor knockout mice exhibit a dysfunctional neutrophil response to infection. The neutrophils are unable to cross epithelial barriers and therefore accumulate in large quantities the subepithelial tissue. Unable to clear the infection, the mice develop swollen kidneys, neutrophil abscesses, high numbers of bacteria and renal scarring.
Species:  Mouse
Tissue: 
Technique:  Gene targeting in embryonic stem cells.
References:  14,18
Phenotypes, Alleles and Disease Models Mouse data from MGI

Click here to show/hide data

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002334 abnormal airway responsiveness PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0002397 abnormal bone marrow morphology PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0008721 abnormal chemokine level PMID: 11801688 
Cxcr2tm1Mwm|Dstncorn1 Dstncorn1/Dstncorn1,Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * A/WySn * BALB/c * brachy stock		 MGI:105303  MGI:1929270  MP:0001312 abnormal cornea morphology PMID: 18628996 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0003009 abnormal cytokine secretion PMID: 11714818 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002465 abnormal eosinophil physiology PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0008111 abnormal granulocyte differentiation PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0008751 abnormal interleukin level PMID: 11801688  14707102 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002442 abnormal leukocyte physiology PMID: 15356099 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0002348 abnormal lymph node medulla PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0000920 abnormal myelination PMID: 12176324 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0001601 abnormal myelopoiesis PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0001601 abnormal myelopoiesis PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002463 abnormal neutrophil physiology PMID: 11801688  15466624 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0002463 abnormal neutrophil physiology PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0008042 abnormal NK T cell physiology PMID: 11123307 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002281 abnormal respiratory mucosa goblet cell morphology PMID: 12626595 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0000955 abnormal spinal cord morphology PMID: 12176324 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0002357 abnormal spleen white pulp morphology PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002444 abnormal T cell physiology PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0005465 abnormal T-helper 1 physiology PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0005466 abnormal T-helper 2 physiology PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
B6.Cg-Il8rb		 MGI:105303  MP:0003448 altered tumor morphology PMID: 14978086 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0005542 corneal vascularization PMID: 14707102 
Cxcr2tm1Mwm|Dstncorn1 Dstncorn1/Dstncorn1,Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * A/WySn * BALB/c * brachy stock		 MGI:105303  MGI:1929270  MP:0005542 corneal vascularization PMID: 18628996 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002335 decreased airway responsiveness PMID: 12626595 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0001265 decreased body size PMID: 16094689 
Cxcr2tm1(IL8RB)Dktr Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
involves: 129S2/SvPas * C57BL/6		 MGI:105303  MP:0003918 decreased kidney weight PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
B6.Cg-Il8rb		 MGI:105303  MP:0001273 decreased metastatic potential PMID: 14978086 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0000954 decreased oligodendrocyte progenitor number PMID: 12176324 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0009764 decreased sensitivity to induced morbidity/mortality PMID: 14500678 
Cxcr2tm1(IL8RB)Dktr Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
involves: 129S2/SvPas * C57BL/6		 MGI:105303  MP:0004953 decreased spleen weight PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0005398 decreased susceptibility to fungal infection PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0003436 decreased susceptibility to induced arthritis PMID: 19109198 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0004956 decreased thymus weight PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
B6.Cg-Il8rb		 MGI:105303  MP:0003447 decreased tumor growth/size PMID: 14978086 
Cxcr2tm1Mwm|Tg(TRAMP)8247Ng Cxcr2tm1Mwm/Cxcr2tm1Mwm,Tg(TRAMP)8247Ng/?
involves: 129S2/SvPas * BALB/c * C57BL/6		 MGI:105303  MGI:2680364  MP:0003447 decreased tumor growth/size PMID: 16941672 
Cxcr2+|Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2+
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002908 delayed wound healing PMID: 10951241 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002908 delayed wound healing PMID: 10951241 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0008542 enlarged cervical lymph nodes PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0000702 enlarged lymph nodes PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0000691 enlarged spleen PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0000240 extramedullary hematopoiesis PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0008720 impaired neutrophil migration PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0008720 impaired neutrophil migration PMID: 11069247  11714818 
Cxcr2+|Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2+
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0008719 impaired neutrophil recruitment PMID: 10951241 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0008719 impaired neutrophil recruitment PMID: 10951241  11046063  15385471 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0005014 increased B cell number PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0008596 increased circulating interleukin-6 level PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0004928 increased epididymis weight PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0000322 increased granulocyte number PMID: 16094689 
Cxcr2tm1(IL8RB)Dktr Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
involves: 129S2/SvPas * C57BL/6		 MGI:105303  MP:0000322 increased granulocyte number PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002497 increased IgE level PMID: 11801688 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0003917 increased kidney weight PMID: 16094689 
Cxcr2tm1(IL8RB)Dktr Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
involves: 129S2/SvPas * C57BL/6		 MGI:105303  MP:0000218 increased leukocyte cell number PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0000219 increased neutrophil cell number PMID: 8036519 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0004909 increased seminal vesicle weight PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * BALB/c		 MGI:105303  MP:0004952 increased spleen weight PMID: 16094689 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002412 increased susceptibility to bacterial infection PMID: 11069247 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0005027 increased susceptibility to parasitic infection PMID: 11714818 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
C.129S2(B6)-Cxcr2/J		 MGI:105303  MP:0002418 increased susceptibility to viral infection PMID: 14707102 
Cxcr2tm1Mwm Cxcr2tm1Mwm/Cxcr2tm1Mwm
involves: 129S2/SvPas * C57BL/6J		 MGI:105303  MP:0010373 myeloid hyperplasia PMID: 8036519 
Cxcr2tm1(IL8RB)Dktr Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
involves: 129S2/SvPas * C57BL/6		 MGI:105303  MP:0002768 small adrenal glands PMID: 16094689 
Cxcr2tm1(IL8RB)Dktr Cxcr2tm1(IL8RB)Dktr/Cxcr2tm1(IL8RB)Dktr
involves: 129S2/SvPas * C57BL/6		 MGI:105303  MP:0000601 small liver PMID: 16094689 
Biologically Significant Variants
The Cys785 -> Thr polymorphism may be associated with a reduced risk of developing chronic obstructive pulmonary disease.
Type:  Single nucleotide polymorphism.
Species:  Human
References:  28

REFERENCES

Show »

1. Abonia, J. P., Austen, K. F., Rollins, B. J., Joshi, S. K., Flavell, R. A., Kuziel, W. A., Koni, P. A. and Gurish, M. F. (2005) Constitutive homing of mast cell progenitors to the intestine depends on autologous expression of the chemokine receptor CXCR2. Blood, 105: 4308-4313. [PMID:15705791]

2. Addison, C. L., Daniel, T. O., Burdick, M. D., Liu, H., Ehlert, J. E., Xue, Y. Y., Buechi, L., Walz, A., Richmond, A. and Strieter, R. M. (2000) The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity. J Immunol, 165: 5269-5277. [PMID:11046061]

3. Ahuja, S. K. and Murphy, P. M. (1996) The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem, 271: 20545-20550. [PMID:8702798]

4. Bertini, R., Allegretti, M., Bizzarri, C., Moriconi, A., Locati, M., Zampella, G., Cervellera, M. N., Di Cioccio, V., Cesta, M. C., Galliera, E., Martinez, F. O., Di Bitondo, R., Troiani, G., Sabbatini, V., D'Anniballe, G., Anacardio, R., Cutrin, J. C., Cavalieri, B., Mainiero, F., Strippoli, R., Villa, P., Di Girolamo, M., Martin, F., Gentile, M., Santoni, A., Corda, D., Poli, G., Mantovani, A., Ghezzi, P. and Colotta, F. (2004) Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci U S A, 101: 11791-11796. [PMID:15282370]

5. Boisvert, W. A., Santiago, R., Curtiss, L. K. and Terkeltaub, R. A. (1998) A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest., 101: 353-363. [PMID:9435307]

6. Bozic, C. R., Gerard, N. P., von Uexkull-Guldenband, C., Kolakowski, L. F., Conklyn, M. J., Breslow, R., Showell, H. J. and Gerard, C. (1994) The murine interleukin 8 type B receptor homologue and its ligands. Expression and biological characterization. J Biol Chem, 269: 29355-29358. [PMID:7961909]

7. Broxmeyer, H. E., Cooper, S., Cacalano, G., Hague, N. L., Bailish, E. and Moore, M. W. (1996) Involvement of Interleukin (IL) 8 receptor in negative regulation of myeloid progenitor cells in vivo: evidence from mice lacking the murine IL-8 receptor homologue. J Exp Med, 184: 1825-1832. [PMID:8920870]

8. Del Rio, L., Bennouna, S., Salinas, J. and Denkers, E. Y. (2001) CXCR2 deficiency confers impaired neutrophil recruitment and increased susceptibility during Toxoplasma gondii infection. J Immunol, 167: 6503-6509. [PMID:11714818]

9. Devalaraja, R. M., Nanney, L. B., Du, J., Qian, Q., Yu, Y., Devalaraja, M. N. and Richmond, A. (2000) Delayed wound healing in CXCR2 knockout mice. J Invest Dermatol, 115: 234-244. [PMID:10951241]

10. Doroshenko, T., Chaly, Y., Savitskiy, V., Maslakova, O., Portyanko, A., Gorudko, I. and Voitenok, N. N. (2002) Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2. Blood, 100: 2668-2671. [PMID:12239185]

11. Dunstan, C. A., Salafranca, M. N., Adhikari, S., Xia, Y., Feng, L. and Harrison, J. K. (1996) Identification of two rat genes orthologous to the human interleukin-8 receptors. J Biol Chem, 271: 32770-32776. [PMID:8955112]

12. Farkas, L., Hahn, M. C., Schmoczer, M., Jentsch, N., Krätzel, K., Pfeifer, M. and Schulz, C. (2005) Expression of CXC chemokine receptors 1 and 2 in human bronchial epithelial cells. Chest, 128: 3724-3734. [PMID:16304340]

13. Feniger-Barish, R., Yron, I., Meshel, T., Matityahu, E. and Ben-Baruch, A. (2003) IL-8-induced migratory responses through CXCR1 and CXCR2: association with phosphorylation and cellular redistribution of focal adhesion kinase. Biochemistry, 42: 2874-2886. [PMID:12627953]

14. Godaly, G., Hang, L., Frendéus, B. and Svanborg, C. (2000) Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice. J Immunol, 165: 5287-5294. [PMID:11046063]

15. Gonçalves, A. S. and Appelberg, R. (2002) The involvement of the chemokine receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in Mycobacterium avium infection. Scand J Immunol, 55: 585-591. [PMID:12028561]

16. Hall, D. A., Beresford, I. J., Browning, C. and Giles, H. (1999) Signalling by CXC-chemokine receptors 1 and 2 expressed in CHO cells: a comparison of calcium mobilization, inhibition of adenylyl cyclase and stimulation of GTPgammaS binding induced by IL-8 and GROalpha. Br J Pharmacol, 126: 810-818. [PMID:10188995]

17. Hall, L. R., Diaconu, E., Patel, R. and Pearlman, E. (2001) CXC chemokine receptor 2 but not C-C chemokine receptor 1 expression is essential for neutrophil recruitment to the cornea in helminth-mediated keratitis (river blindness). J Immunol, 166: 4035-4041. [PMID:11238651]

18. Hang, L., Frendéus, B., Godaly, G. and Svanborg, C. (2000) Interleukin-8 receptor knockout mice have subepithelial neutrophil entrapment and renal scarring following acute pyelonephritis. J Infect Dis, 182: 1738-1748. [PMID:11069247]

19. Horuk, R., Martin, A. W., Wang, Z., Schweitzer, L., Gerassimides, A., Guo, H., Lu, Z., Hesselgesser, J., Perez, H. D., Kim, J., Parker, J., Hadley, T. J. and Peiper, S. C. (1997) Expression of chemokine receptors by subsets of neurons in the central nervous system. J Immunol, 158: 2882-2890. [PMID:9058825]

20. Iikura, M., Miyamasu, M., Yamaguchi, M., Kawasaki, H., Matsushima, K., Kitaura, M., Morita, Y., Yoshie, O., Yamamoto, K. and Hirai, K. (2001) Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol, 70: 113-120. [PMID:11435493]

21. Johnston, R. A., Mizgerd, J. P. and Shore, S. A. (2005) CXCR2 is essential for maximal neutrophil recruitment and methacholine responsiveness after ozone exposure. Am J Physiol Lung Cell Mol Physiol, 288: L61-L67. [PMID:15361358]

22. Jones, S. A., Dewald, B., Clark-Lewis, I. and Baggiolini, M. (1997) Chemokine antagonists that discriminate between interleukin-8 receptors. Selective blockers of CXCR2. J Biol Chem, 272: 16166-16169. [PMID:9195914]

23. Jones, S. A., Wolf, M., Qin, S., Mackay, C. R. and Baggiolini, M. (1996) Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci U S A, 93: 6682-6686. [PMID:8692878]

24. Kielian, T., Barry, B. and Hickey, W. F. (2001) CXC chemokine receptor-2 ligands are required for neutrophil-mediated host defense in experimental brain abscesses. J Immunol, 166: 4634-4643. [PMID:11254722]

25. Lee, J., Horuk, R., Rice, G. C., Bennett, G. L., Camerato, T. and Wood, W. I. (1992) Characterization of two high affinity human interleukin-8 receptors. J Biol Chem, 267: 16283-16287. [PMID:1379593]

26. Li, A., Dubey, S., Varney, M. L. and Singh, R. K. (2002) Interleukin-8-induced proliferation, survival, and MMP production in CXCR1 and CXCR2 expressing human umbilical vein endothelial cells. Microvasc Res, 64: 476-481. [PMID:12453441]

27. Ludwig, A., Ehlert, J. E., Flad, H. D. and Brandt, E. (2000) Identification of distinct surface-expressed and intracellular CXC-chemokine receptor 2 glycoforms in neutrophils: N-glycosylation is essential for maintenance of receptor surface expression. J Immunol, 165: 1044-1052. [PMID:10878382]

28. Matheson, M. C., Ellis, J. A., Raven, J., Walters, E. H. and Abramson, M. J. (2006) Association of IL8, CXCR2 and TNF-alpha polymorphisms and airway disease. J Hum Genet, : -. [PMID:16429233]

29. Merz, D., Liu, R., Johnson, K. and Terkeltaub, R. (2003) IL-8/CXCL8 and growth-related oncogene alpha/CXCL1 induce chondrocyte hypertrophic differentiation. J Immunol, 171: 4406-4415. [PMID:14530367]

30. Meucci, O., Fatatis, A., Simen, A. A., Bushell, T. J., Gray, P. W. and Miller, R. J. (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci U S A, 95: 14500-14505. [PMID:9826729]

31. Mihara, K., Smit, M. J., Krajnc-Franken, M., Gossen, J., Rooseboom, M. and Dokter, W. (2005) Human CXCR2 (hCXCR2) takes over functionalities of its murine homolog in hCXCR2 knockin mice. Eur J Immunol, 35: 2573-2582. [PMID:16094689]

32. Milatovic, S., Nanney, L. B., Yu, Y., White, J. R. and Richmond, A. (2003) Impaired healing of nitrogen mustard wounds in CXCR2 null mice. Wound Repair Regen, 11: 213-219. [PMID:12753603]

33. Miller, A. L., Strieter, R. M., Gruber, A. D., Ho, S. B. and Lukacs, N. W. (2003) CXCR2 regulates respiratory syncytial virus-induced airway hyperreactivity and mucus overproduction. J Immunol, 170: 3348-3356. [PMID:12626595]

34. Murphy, P. M. and Tiffany, H. L. (1991) Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science, 253: 1280-1283. [PMID:1891716]

35. Neptune, E. R. and Bourne, H. R. (1997) Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc Natl Acad Sci U S A, 94: 14489-14494. [PMID:9405640]

36. Nilsson, G., Mikovits, J. A., Metcalfe, D. D. and Taub, D. D. (1999) Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB. Blood, 93: 2791-2797. [PMID:10216072]

37. Ochensberger, B., Tassera, L., Bifrare, D., Rihs, S. and Dahinden, C. A. (1999) Regulation of cytokine expression and leukotriene formation in human basophils by growth factors, chemokines and chemotactic agonists. Eur J Immunol, 29: 11-22. [PMID:9933081]

38. Richardson, R. M., Marjoram, R. J., Barak, L. S. and Snyderman, R. (2003) Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation. J Immunol, 170: 2904-2911. [PMID:12626541]

39. Tarzami, S. T., Miao, W., Mani, K., Lopez, L., Factor, S. M., Berman, J. W. and Kitsis, R. N. (2003) Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection. Circulation, 108: 2387-2392. [PMID:14568904]

40. White, J. R., Lee, J. M., Young, P. R., Hertzberg, R. P., Jurewicz, A. J., Chaikin, M. A., Widdowson, K., Foley, J. J., Martin, L. D., Griswold, D. E. and Sarau, H. M. (1998) Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J. Biol. Chem., 273: 10095-10098. [PMID:9553055]

41. Wilson, S., Wilkinson, G. and Milligan, G. (2005) The CXCR1 and CXCR2 receptors form constitutive homo- and heterodimers selectively and with equal apparent affinities. J Biol Chem, 280: 28663-28674. [PMID:15946947]

42. Wolf, M., Delgado, M. B., Jones, S. A., Dewald, B., Clark-Lewis, I. and Baggiolini, M. (1998) Granulocyte chemotactic protein 2 acts via both IL-8 receptors, CXCR1 and CXCR2. Eur J Immunol, 28: 164-170. [PMID:9485196]

43. Wu, L., Ruffing, N., Shi, X., Newman, W., Soler, D., Mackay, C. R. and Qin, S. (1996) Discrete steps in binding and signaling of interleukin-8 with its receptor. J Biol Chem, 271: 31202-31209. [PMID:8940121]

44. Wuyts, A., Proost, P., Lenaerts, J. P., Ben-Baruch, A., Van Damme, J. and Wang, J. M. (1998) Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78. Eur J Biochem, 255: 67-73. [PMID:9692902]

45. Wuyts, A., Van Osselaer, N., Haelens, A., Samson, I., Herdewijn, P., Ben-Baruch, A., Oppenheim, J. J., Proost, P. and Van Damme, J. (1997) Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry, 36: 2716-2723. [PMID:9054580]

46. Zernecke, A., Weber, K. S., Erwig, L. P., Kluth, D. C., Schröppel, B., Rees, A. J. and Weber, C. (2001) Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis. J Immunol, 166: 5755-5762. [PMID:11313419]

To cite this database page, please use the following:

Israel F. Charo, Rebecca Hills, Richard Horuk, Kouji Matsushima, Philip M. Murphy, Joost J. Oppenheim.
Chemokine receptors: CXCR2. Last modified on 31/01/2013. Accessed on 20/05/2013. IUPHAR database (IUPHAR-DB), http://www.iuphar-db.org/DATABASE/ObjectDisplayForward?objectId=69.


Contact us | Print | Back to top | Help